Anavex Life Sciences Corp (NASDAQ:AVXL) closed at $20.99 after surging 35.42% yesterday in the trading session. However, in the after-hours, the stock was down 2.14% and was trading for $20.54. Yet, AVXL is at a higher price than its previous close of $15.50. It is closer to its average daily range of $16.70 – $22.24. AVXL has a huge market capitalization of $1.47 billion, and on average, its share trading volume in the market is 970.96K.
Founded in 2004, this New York-headquartered biopharmaceutical company soared on account of its new publication that came in a medical journal. The publication elucidates the working of ANAVEX®3-71 (AF710B) and ANAVEX®2-73 (blarcamesine), its two essential products in treating Alzheimer’s disease.
The company, in its recent announcement, also elaborated about the publication and featuring of its products. At the same time, the report highlights an explanation of the relevance of these products. The publication has pushed the shares up. Anavex Life Sciences Corp is known for developing differentiated therapeutics to treat neurodevelopmental and neurodegenerative disorders.